Echosens Expands Presence in South Asia
Echosens, a leader in non-invasive liver diagnostics, has opened a new regional headquarters in Mumbai, India.
The new office will serve as a hub for operations across South Asia, including India, Bangladesh, Bhutan, The Maldives, Nepal, and Sri Lanka, expanding access to FibroScan.
The establishment of the South Asia headquarters underscores the company's long-term commitment to advancing liver health in a region where metabolic dysfunction-associated steatotic liver disease (MASLD) and other chronic liver conditions are on the rise.
- MASLD affects an estimated 38.6% of adults and 35.4% of children in India.
- Among people living with type 2 diabetes, the prevalence is as high as 70%.
Echosens has been present in India for over 15 years, earning wide acceptance among the medical community.
Author's summary: Echosens strengthens liver health commitment in South Asia.
More News
- Municipal early voter turnout in New Hanover County is up significantly
- EXCLUSIVE: Dan Fogelman gives updates on 'Paradise' and details first days of filming his new show
- Victory for Health Rights in Benevento
- Santander Consumer Bank begins offering Guaranteed Investment Certificates in Canada
- New coach leads Genoa to first win of season against Sassuolo
- Good Vines, Even Better Wines
- Pordenone's Low Crime Rate and Campania's Challenges
- Cycling Eurovelo 3, from Northern France to Belgium
- Two dead, one injured in suspected drunk driving crash on State Road 120
- Somalia’s eVisa Fiasco: Bureaucracy Without Legitimacy - WardheerNews